Lingna N. Li

Tianjin, 301600, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States.

Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States.

Journal: Cancers
Published: October 23, 2025

Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma.

Development of a Cytogenetic Double-Hit Model for Survival Prediction in Multiple Myeloma.

Journal: Cancers
Published: July 28, 2025

T(11;14) with multiple myeloma: Standard risk survival but slow and poor response.

T(11;14) with multiple myeloma: Standard risk survival but slow and poor response.

Journal: Annals of hematology
Published: August 15, 2024

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Journal: Leukemia
Published: May 26, 2024

Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia

Angioimmunoblastic T-cell lymphoma with monoclonal B cell and plasma cell hyperplasia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 04, 2023

MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities.

MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities.

Journal: Haematologica
Published: November 15, 2023

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.

Journal: Leukemia
Published: November 13, 2023

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).

Journal: Annals of hematology
Published: October 12, 2023

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.

The age-dependent changes in risk weights of the prognostic factors for multiple myeloma.

Journal: Hematology (Amsterdam, Netherlands)
Published: September 19, 2023

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 19, 2023

Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review.

Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review.

Journal: Annals of hematology
Published: August 19, 2023

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma.

Journal: Haematologica
Published: May 14, 2023
Showing 1-12 of 18

Last Updated: 09/26/2026